湖南科技监管部门就获五项基金资助的AI造假肿瘤论文调查湘雅二医院

Hunan science regulators probe Second Xiangya Hospital over five-grant cancer study mocked for AI-faked tumors

核实信源 (3)一手报道与开源情报 (OSINT) 记录
  • 湖南省科学技术厅于11月17日责成中南大学湘雅二医院,就一篇发表于《转化医学杂志》(Journal of Translational Medicine)、标注五项公共科研资助(含两项国家自然科学基金项目82303258与82203161)的论文展开调查。 Hunan's Department of Science and Technology ordered Second Xiangya Hospital on November 17 to probe a Journal of Translational Medicine paper listing five public grants, including two National Natural Science Foundation awards (82303258 and 82203161).
  • 中国网民发现,该论文标尺中一厘米竟包含十二毫米,小鼠肿瘤照片形似火锅虾滑且质地如花岗岩,细胞活性表述与图2曲线自相矛盾,首页还将“湖南”误印为“Human”(即“Changsha, Human”),邮编写作“41001l”。 Chinese netizens spotted rulers with twelve millimeters per centimeter, tumor photos resembling hotpot shrimp paste with granite-like density, cell-viability claims contradicting Figure 2 curves, and 'Changsha, Human' with postal code '41001l.'
  • 高校与资助机构长期怠于监管,直到相关嘲讽冲上微博热搜才被迫回应;这与兰州大学2026年6月就一篇带有豆包AI水印的论文启动调查后至今毫无下文如出一辙。 Universities and funding bodies stalled oversight until viral mockery hit Weibo Hot Search, mirroring Lanzhou University's unanswered June 2026 probe into a paper carrying a Doubao AI watermark.
中文简报 (Chinese Dispatch)

据极目新闻与凤凰新闻报道,在网民曝光论文中违反常识的标尺与造假肿瘤照片后,湖南省科技厅于11月17日责成中南大学湘雅二医院对一项获五项基金资助的癌症研究展开调查。该论文的破绽一目了然。这篇发表于《转化医学杂志》(Journal of Translational Medicine)、通讯作者署名为Lin Zhao的文章声称微塑料会加剧鼻咽癌恶化,所配小鼠肿瘤照片却被网民嘲讽像火锅虾滑。文中标尺将十二毫米硬塞进一厘米,曲线明明显示九成细胞死亡,正文却宣称细胞生长;首页更是将“长沙,湖南”印成“Changsha, Human”,邮编写作“41001l”。第16页则列出了国家自然科学基金82303258与82203161,以及两项湖南省基金和一项医院启动基金。

湘雅二医院此前已有丑闻前科。2024年,法院以对患者实施不必要手术等罪名判处该院副主任医师刘翔峰有期徒刑十七年,另有十五名医务人员受到处分。今天的闹剧暴露了公立医院内部的门面式合规:考核指标将薪酬和职称与海外期刊影响因子直接挂钩,变相奖励临床医生将未经核查的AI生成内容塞进收费期刊。官僚庇护则维系着这条造假链条——兰州大学就一篇带有豆包AI水印的论文启动调查五个月后,当局至今未公布任何结果,这与上海临床试验隐瞒致死案如出一辙。

公共财政买单的却是伪科学。放任学术造假不仅会污染临床医生用于癌症诊疗的医学文献,也在挤占真正开展实验的实验室本就稀缺的公共经费。截至11月18日,国家自然科学基金委与施普林格·自然(Springer Nature)均未采取任何行动。只要北京不废除唯指标论的医院排名体系,中国纳税人就将继续为AI幻觉买单,而期刊的把关只能靠网民自己来充当。

英文原文 (English Original)

Hunan’s science department ordered Second Xiangya Hospital on November 17 to investigate a five-grant cancer study after netizens exposed impossible rulers and fake tumor photos, Jimu News and Phoenix News reported. The paper failed on sight. Published in Journal of Translational Medicine under corresponding author Lin Zhao, it claims microplastics worsen nasopharyngeal cancer while showing mouse tumors mocked as hotpot shrimp paste. Scale bars cram twelve millimeters into one centimeter, curves show 90 percent cell death beside claims of growth, and page one prints “Changsha, Human” with postal code “41001l.” Page sixteen lists National Natural Science Foundation grants 82303258 and 82203161 alongside two Hunan grants and a hospital start-up fund.

Second Xiangya Hospital has weathered scandals before. In 2024, courts jailed deputy chief surgeon Liu Xiangfeng for seventeen years over unnecessary operations, prompting penalties against fifteen staff. Today’s farce exposes Potemkin compliance inside state hospitals, where quotas tie pay and titles to foreign impact factors, rewarding clinicians who push unvetted AI output through fee-charging journals. Bureaucratic shielding protects the pipeline: five months after Lanzhou University probed a paper bearing a Doubao AI watermark, officials have published nothing, echoing Shanghai’s clinical trial cover-up.

Public money bought fake science. Unchecked fabrication corrupts medical literature doctors consult for cancer care while draining scarce public grants away from labs running real experiments. Neither the National Natural Science Foundation nor Springer Nature had acted by November 18. Until Beijing scraps quota-driven hospital rankings, Chinese taxpayers fund AI illusions while netizens police the journals.

中国民间与网络舆论

该论文截图在B站、知乎和微博热搜迅速刷屏,网民戏称肿瘤照片像“火锅虾滑”,并调侃“人类省”(Human Province)科研领先全球。在嘲讽之外,一线临床医生在知乎上表达了强烈不满,质问为何粗制滥造的论文能轻松登上影响因子9.7的期刊并套取国家经费,而踏实做实验的真正研究却屡屡遭拒。

Screenshots of the paper went viral across Bilibili, Zhihu, and Weibo Hot Search, where commenters mocked the tumor photos as hotpot shrimp paste and joked that 'Human Province' leads the world in science. Beneath the satire, working clinicians voiced bitter frustration on Zhihu, asking why fabricated manuscripts sail into impact-factor-9.7 journals and claim state grants while genuine lab studies face rejection.

审查机制与信息管控

自2025年12月该论文发表以来,近一年间院内科研监管部门与高校办公室对显而易见的异常视而不见,宛如兰州大学在2026年6月一篇论文被曝带有豆包AI水印后长达五个月的沉默。直到11月17日B站与微信上的民间监督者引爆全国微博群嘲,医院和省科技厅才发布措辞简短的确认通报,但仍未公开作者详细信息及基金审计记录。

Internal research monitors and university offices ignored obvious anomalies for nearly a year after the paper's December 2025 publication, mirroring Lanzhou University's five-month silence after a June 2026 paper carried a Doubao AI watermark. Only when independent watchdogs on Bilibili and WeChat triggered nationwide Weibo mockery on November 17 did hospital and provincial science offices issue terse confirmations while withholding author details and grant audit records.

背景脉络与深度解析

涉事论文题为《Ferroptosis inhibition via the ROS-GPX4 axis drives microplastic-induced malignant progression of nasopharyngeal carcinoma》(《通过ROS-GPX4轴抑制铁死亡驱动微塑料诱导的鼻咽癌恶性进展》),通讯作者为中南大学湘雅二医院病理科的Lin Zhao,标注资助包括两项国家自然科学基金(82303258、82203161)、两项湖南省自然科学基金(2023JJ40874、2023JJ40815)及医院启动基金QH20230202。2024年,湘雅二医院曾因副主任医师刘翔峰对患者实施不必要手术而被判处十七年有期徒刑,引发舆论公愤。

The paper, 'Ferroptosis inhibition via the ROS-GPX4 axis drives microplastic-induced malignant progression of nasopharyngeal carcinoma,' lists corresponding author Lin Zhao at Second Xiangya Hospital's Department of Pathology alongside two National Natural Science Foundation grants (82303258, 82203161), two Hunan Provincial Natural Science Foundation grants (2023JJ40874, 2023JJ40815), and hospital start-up fund QH20230202. Second Xiangya Hospital previously faced public outrage in 2024 when deputy chief surgeon Liu Xiangfeng received a seventeen-year prison sentence for performing unnecessary operations on patients.